Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6640]

ASCO 2023: Results of SWOG S1929 trial show small-cell lung cancer patients with SLFN11 expression can benefit from PARP inhibitor added to immune checkpoint blockade

ASCO 2023: Results of SWOG S1929 trial show small-cell lung cancer patients with SLFN11 expression can benefit...

First-of-its-kind open-analysis platform for paediatric brain tumours provides robust data resource for childhood cancer research

First-of-its-kind open-analysis platform for paediatric brain tumours provides robust data resource for childhood...

Initiative will test new drug combinations guided by tumour biology

Initiative will test new drug combinations guided by tumour biology

ASCO 2023: Alternate response criteria may allow early outcome prediction in pancreatic neuroendocrine tumours

ASCO 2023: Alternate response criteria may allow early outcome prediction in pancreatic neuroendocrine tumours

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

FDA approves blue earth diagnostics’ flotufolastat F 18 injection, first radiohybrid PSMA-targeted PET imaging agent for prostate cancer

FDA approves blue earth diagnostics’ flotufolastat F 18 injection, first radiohybrid PSMA-targeted PET imaging...

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

A metabolic process in cancer cells could unlock a possible treatment for glioblastoma

A metabolic process in cancer cells could unlock a possible treatment for glioblastoma

Blocking a key immune protein improves radiation therapy for cancer

Blocking a key immune protein improves radiation therapy for cancer

Blocking a key immune protein improves radiation therapy for cancer

Blocking a key immune protein improves radiation therapy for cancer

More from ecancer